Related references
Note: Only part of the references are listed.LRRK2 and Human Disease: A Complicated Question or a Question of Complexes?
Patrick A. Lewis et al.
SCIENCE SIGNALING (2012)
α-Synuclein Aggregation and Transmission Are Enhanced by Leucine-Rich Repeat Kinase 2 in Human Neuroblastoma SH-SY5Y Cells
Kazunari Kondo et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
Martin C. Herzig et al.
HUMAN MOLECULAR GENETICS (2011)
Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake
Hongxia Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2
Julien Dusonchet et al.
JOURNAL OF NEUROSCIENCE (2011)
LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
Giovanni Piccoli et al.
JOURNAL OF NEUROSCIENCE (2011)
Replication of MAPT and SNCA, but not PARK16-18, as Susceptibility Genes for Parkinson's Disease
Ignacio F. Mata et al.
MOVEMENT DISORDERS (2011)
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Zhihua Liu et al.
NATURE IMMUNOLOGY (2011)
Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
B. Winner et al.
NEUROBIOLOGY OF DISEASE (2011)
Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
David Ramonet et al.
PLOS ONE (2011)
Neuropathology in Mice Expressing Mouse Alpha-Synuclein
Claus Rieker et al.
PLOS ONE (2011)
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas
Brendan D. Looyenga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
Vincent Plagnol et al.
PLOS GENETICS (2011)
Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Todd L. Edwards et al.
ANNALS OF HUMAN GENETICS (2010)
Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathway
Iria Carballo-Carbajal et al.
CELLULAR SIGNALLING (2010)
Analysis of 39 Crohn's Disease Risk Loci in Swedish Inflammatory Bowel Disease Patients
Leif Torkvist et al.
INFLAMMATORY BOWEL DISEASES (2010)
Leucine-Rich Repeat Kinase 2 Is Associated With the Endoplasmic Reticulum in Dopaminergic Neurons and Accumulates in the Core of Lewy Bodies in Parkinson Disease
Jeremie Vitte et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of the Drosophila Neuromuscular Junction
Seongsoo Lee et al.
JOURNAL OF NEUROSCIENCE (2010)
LRRK2 G2019S Mutation Induces Dendrite Degeneration through Mislocalization and Phosphorylation of Tau by Recruiting Autoactivated GSK3β
Chin-Hsien Lin et al.
JOURNAL OF NEUROSCIENCE (2010)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
LRRK2 G2019S Mutations are Associated with an Increased Cancer Risk in Parkinson Disease
Rachel Saunders-Pullman et al.
MOVEMENT DISORDERS (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Christian Wider et al.
NEURODEGENERATIVE DISEASES (2010)
The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation
Azad Kumar et al.
PLOS ONE (2010)
The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy
Derya R. Shimshek et al.
PLOS ONE (2010)
Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
Hong Qing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain
Kenneth D. Cronin et al.
HUMAN MOLECULAR GENETICS (2009)
Formation and development of Lewy pathology: a critical update
Kurt A. Jellinger
JOURNAL OF NEUROLOGY (2009)
Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis
Loukia Parisiadou et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuropathology of Parkinson's Disease with the R1441G Mutation in LRRK2
Jose-Felix Marti-Masso et al.
MOVEMENT DISORDERS (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
Xian Lin et al.
NEURON (2009)
Genomewide Association Study of Leprosy
Fu-Ren Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China
X. -K. An et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
LRRK2 regulates synaptic vesicle endocytosis
Narae Shin et al.
EXPERIMENTAL CELL RESEARCH (2008)
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
Edward D. Plowey et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease
J. Alegre-Abarrategui et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
The role of common genetic risk variants in Parkinson disease
E-K Tan
CLINICAL GENETICS (2007)
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8
W. C. Nichols et al.
NEUROLOGY (2007)
Apoptotic mechanisms in mutant LRRK2-mediated cell death
Ciro Iaccarino et al.
HUMAN MOLECULAR GENETICS (2007)
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Carles Gaig et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation
Maria Teresa Giordana et al.
MOVEMENT DISORDERS (2007)
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Matthew J. Farrer et al.
PARKINSONISM & RELATED DISORDERS (2007)
The familial parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al.
NEURON (2006)
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
A. Rajput et al.
NEUROLOGY (2006)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease
Demetrius M. Maraganore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Biochemical and pathological characterization of Lrrk2
BI Giasson et al.
ANNALS OF NEUROLOGY (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Effect of allelic variation at the NACP-Rep1 repeat upstream of the α-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system
O Chiba-Falek et al.
HUMAN MOLECULAR GENETICS (2001)
α-synuclein gene haplotypes are associated with Parkinson's disease
M Farrer et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
